.After antibody-drug conjugate (ADC) specialist Seagen was offered to Pfizer in 2013 for a tremendou...
.On the heels of a period 3 gain that neglected to excite entrepreneurs, Ironwood Pharmaceuticals is...
.Don't cease Monte Rosa Therapies now. The Boston-based biotech is enjoying after signing a deal wit...
.Accept to this week's Chutes & Ladders, our summary of significant management hirings, shootings...
.Celebrating his firm's upsized initial public offering (IPO), Septerna CEO Jeffrey Finer sounded th...
.AbbVie has actually come back to the resource of its antipsychotic powerhouse Vraylar in search of ...
.GenSight Biologics is weeks away from running out of money. Once more. The biotech only possesses s...
.Monopar Therapeutics is actually recouping a medicine from the scrap heap of AstraZeneca's rare dis...
.Along with brand new information out on Arcus Biosciences' experimental HIF-2a prevention, one grou...
.After creating a genetics treatment collaboration with Dyno Therapeutics in 2020, Roche is back for...